News

Weight-loss drugs may be covered by Medicare, Medicaid under experimental program
A move to cover expensive weight-loss drugs for Americans on Medicare and Medicaid may be in the works, but any such program ...
US Plans to Test Medicare, Medicaid Coverage for Weight-Loss Drugs, Washington Post Reports
According to the Washington Post, 13 states currently cover the drugs for Medicaid patients, while Medicare prohibits ...
Feds Launch Experiment to Have Medicare Cover GLP-1 Weight Loss Drugs
The federal government is expected to start a 5-year-long experiment that will provide some limited coverage of obesity ...
Trump’s Weight-Loss Experiment Could Aid Lilly, Novo. Cost Is Still a Problem.
The Washington Post reported the CMS is considering a plan that could allow Medicare plans to pay for the drugs.
Medicare and Medicaid move toward covering Ozempic and other weight loss drugs
Medicare and Medicaid could expand coverage of GLP-1 drugs, such as Ozempic and Wegovy, and pay for patients’ use of the ...
Medicare, Medicaid plan to experiment with covering weight loss drugs
The Trump administration is planning an experiment to cover weight loss drugs under Medicare and Medicaid, potentially ...
US plans Medicare, Medicaid coverage for weight-loss drugs, Washington Post reports
The Trump administration is planning an experiment to cover weight-loss drugs under Medicare and Medicaid, the Washington ...
Fierce Healthcare1h
CMMI considers weight loss drug coverage pilot as Trump IVF pledge slips: reports
The Center for Medicare and Medicaid Innovation may introduce a five-year pilot model to expand access to weight loss drugs, ...
Medicaid, Medicare may cover weight loss drugs under new pilot program: report
Blockbuster weight loss drugs like Wegovy and Zepbound have surged in popularity, but high prices have left them out of reach for many obese Americans.
A Medicare experiment could change who gets Ozempic
A five-year experiment aims to open access to blockbuster GLP‑1 drugs for obesity, something advocates have pushed for years.
Trump Administration Plan Signals Shift Toward Weight-Loss Drug Coverage For Medicare Patients
The Trump administration is planning a five-year test allowing states to cover weight-loss drugs like Ozempic and Wegovy ...